HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Theodore J Kottom Selected Research

Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)

6/2022Preclinical and Toxicology Studies of BRD5529, a Selective Inhibitor of CARD9.
12/2021Additional C-type lectin receptors mediate interactions with Pneumocystis organisms and major surface glycoprotein.
5/2021Survey of the Transcription Factor Responses of Mouse Lung Alveolar Macrophages to Pneumocystis murina.
1/2021Current State of Carbohydrate Recognition and C-Type Lectin Receptors in Pneumocystis Innate Immunity.
10/2020A critical role for CARD9 in pneumocystis pneumonia host defence.
1/2018Dectin-2 Is a C-Type Lectin Receptor that Recognizes Pneumocystis and Participates in Innate Immune Responses.
2/2017Characterization of N-Acetylglucosamine Biosynthesis in Pneumocystis species. A New Potential Target for Therapy.
8/2012Chitinases in Pneumocystis carinii pneumonia.
7/2006Pneumocystis cell wall beta-glucans induce dendritic cell costimulatory molecule expression and inflammatory activation through a Fas-Fas ligand mechanism.
6/2005Pneumocystis cell wall beta-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factor-kappaB-dependent mechanisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Theodore J Kottom Research Topics

Disease

10Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
06/2022 - 06/2005
8Infections
12/2021 - 01/2003
4Pneumonia (Pneumonitis)
01/2017 - 01/2003
2Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2021 - 01/2020
2Cysts
02/2016 - 08/2010
2Inflammation (Inflammations)
07/2015 - 06/2005
1Mycoses (Diseases, Fungus)
06/2022
1Weight Gain
06/2022
1Fibrosis (Cirrhosis)
12/2021
1Porcine Reproductive and Respiratory Syndrome (PRRS)
01/2021
1Lung Injury
10/2020
1Pneumocystis Infections
10/2020
1Starvation
01/2020
1Chronic Obstructive Pulmonary Disease (COPD)
04/2010
1B-Cell Lymphoma (Lymphoma, B Cell)
04/2010
1Leukemia
04/2010

Drug/Important Bio-Agent (IBA)

6GlucansIBA
06/2022 - 01/2003
6CytokinesIBA
01/2021 - 01/2003
5Proteins (Proteins, Gene)FDA Link
06/2022 - 04/2010
3Messenger RNA (mRNA)IBA
12/2021 - 04/2010
3beta-GlucansIBA
08/2010 - 01/2003
2Bleomycin (Blenoxane)FDA LinkGeneric
12/2021 - 01/2020
2C-Type Lectins (C-Type Lectin)IBA
12/2021 - 01/2017
2ChemokinesIBA
01/2021 - 01/2003
2EnzymesIBA
01/2020 - 08/2010
2Fibronectins (Fibronectin)IBA
02/2008 - 11/2003
1BRD5529IBA
06/2022
1Interleukin-6 (Interleukin 6)IBA
06/2022
1Pharmaceutical PreparationsIBA
06/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2022
1indium-bleomycinIBA
12/2021
1nintedanibIBA
12/2021
1Vardenafil Dihydrochloride (Levitra)FDA Link
12/2021
1Galactose (Galactopyranose)FDA LinkGeneric
12/2021
1Glycoproteins (Glycoprotein)IBA
12/2021
1AcetylgalactosamineIBA
12/2021
1Transcription Factors (Transcription Factor)IBA
05/2021
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
01/2021
1Pattern Recognition ReceptorsIBA
01/2021
1Sodium Glutamate (Accent)IBA
01/2021
1Metalloproteases (Metalloproteinases)IBA
01/2021
1SugarsIBA
01/2020
1CB-839IBA
01/2020
1Adenosine Triphosphate (ATP)IBA
01/2020
1GlutaminaseIBA
01/2020
1Glutamine (L-Glutamine)FDA Link
01/2020
1NucleotidesIBA
01/2020
1Phosphates (Orthophosphate)IBA
01/2020
1mouse dectin-2IBA
01/2018
1nikkomycinIBA
02/2017
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2017
1ChitinasesIBA
08/2012
1GlycosphingolipidsIBA
07/2012
1SmokeIBA
04/2010
1LigandsIBA
04/2010
1IntegrinsIBA
02/2008
1NF-kappa B (NF-kB)IBA
06/2005
1VitronectinIBA
11/2003

Therapy/Procedure

1Therapeutics
05/2021